Label: RE-COVR- tripelennamine hydrochloride injection

  • NDC Code(s): 51031-025-25
  • Packager: Kinetic Technologies, LLC
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated February 24, 2022

If you are a consumer or patient please visit this version.

  • DESCRIPTION:

    Tripelennamine hydrochloride is a white, crystalline material which is stable, nonhygroscopic, and readily soluble in water.  Tripelennamine hydrochloride is characterized by its capacity to antagonize many of the pharmacologic effects of histamine.  RE-COVR™ (tripelennamine hydrochloride injection) is supplied as a sterile solution in multiple dose vials containing 20 mg of tripelennamine hydrochloride, USP per mL, and may contain sodium hydroxide for pH adjustment.

  • INDICATIONS:

    For use in horses and cattle in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.  Not for use in beef calves less than 2 months of age, dairy calves, and veal calves.  See package onsert for complete indications for use.

  • DOSAGE AND ADMINISTRATION:

    Horses: Administer intramuscularly only at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight).  This dose may be repeated in 6-12 hours if necessary.

    Cattle:  Administer intravenously or intramuscularly at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight).  This dose may be repeated in 6-12 hours if necessary.  The intravenous route of administration may provide a more rapid onset of action.  Use aseptic technique to administer RE-COVR™ (tripelennamine hydrochloride injection).

    Warm the solution to near body temperature prior to administration.  Intramuscular injection should be made into the heavy musculature of the hind leg or cervical area.

    While venomous snake bites have been treated with antihistaminic drugs, other conjunctive therapy is required because of toxic reactions associated with the protein complex of venom.

    Do not puncture the stopper more than 30 times, use within the 24-month product expiry.

  • STORAGE AND HANDLING:

    Store at 20°C to 25°C (68°F - 77°F), excursions permitted between 15°C to 30°C (59°F and 86°F).  Keep from freezing.  Protect from light.

  • SPL UNCLASSIFIED SECTION

    Manufactured For:

    KineticVet, PO Box 12388, Lexington, KY 40538

    Made in USA

    www.KineticVet.com

    TAKE TIME        OBSERVE LABEL DIRECTIONS

  • SPL UNCLASSIFIED SECTION

    Before using this drug, read package onsert for full prescribing information.

  • WITHDRAWAL PERIODS AND RESIDUE WARNINGS:

    Cattle: Milk taken during treatment and for 24 hours after the last treatment must not be used for human consumption.  Cattle must not be slaughtered for human consumption within 4 days following the last treatment with this drug product.  Not for use in beef calves less than 2 months of age, dairy calves, and veal calves.  A withdrawal period has not been established for this product in pre-ruminating calves.

  • ANIMAL SAFETY WARNINGS:

    Administration of tripelennamine hydrochloride may give rise to excitement, ataxia, and convulsions.

    Central nervous system stimulation in the form of hyperexcitability, nervousness, and muscle tremors lasting up to 20 minutes have been noted in horses following administration.

    Depression of the central nervous system and incoordination may occur when the drug is used at therapeutic dose levels.  Disturbances in gastrointestinal function may occur in some instances.

  • OTHER WARNINGS:

    Horses - Do not use in horses intended for human consumption.

  • USER SAFETY WARNINGS:

    Not for use in humans.  Keep out of reach of children. To obtain a Safety Data Sheet, contact KineticVet at 1-877-786-9882 or www.KineticVet.com.

  • ACTIVE INGREDIENTS:

    Each mL contains 20 mg of tripelennamine hydrochloride USP per mL of aqueous solution.

  • INACTIVE INGREDIENTS:

    Sodium hydroxide may be added to adjust pH.

  • CONTACT INFORMATION:

    Contact KineticVet at (877) 786-9882 or www.KineticVet.com.  To report suspected adverse drug experiences, contact KineticVet at (877) 786-9882.  For additional information about reporting adverse drug experiences for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae.

  • HOW SUPPLIED:

    100 mL, 250 mL and 500 mL multiple dose vials.

  • PATIENT PACKAGE INSERT

    image description

  • PRINCIPAL DISPLAY PANEL

    NDC 51031-025-25

    RE-COVR™ (tripelennamine hydrochloride injection)

    20 mg per mL

    Antihistamine

    Horses - For intramuscular injection only

    Cattle - For intravenous or intramuscular injection

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    KINETICVET

    Net Contents: 250 mL

    Approved by FDA under NADA # 006-417

    image description

  • INGREDIENTS AND APPEARANCE
    RE-COVR 
    tripelennamine hydrochloride injection
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:51031-025
    Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TRIPELENNAMINE HYDROCHLORIDE (UNII: FWV8GJ56ZN) (TRIPELENNAMINE - UNII:3C5ORO99TY) TRIPELENNAMINE20 mg  in 1 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51031-025-25250 mL in 1 BOTTLE, GLASS
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA00641702/24/2022
    Labeler - Kinetic Technologies, LLC (164935731)